nach oben

Clinical Research in Cardiology

Erschienen in:

01.06.2018 | Letter to the Editors

The clinical relevance of drug–drug interaction between co-trimoxazole and sacubitril/valsartan treatment in a heart failure patient: a case report and overview of mechanisms and management in clinical practice

verfasst von: Eleni S. Nakou, Maria E. Marketou, Panos E. Vardas, Fragiskos I. Parthenakis

Erschienen in: Clinical Research in Cardiology | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Excerpt

Sirs: …

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and Committees (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993–1004CrossRefPubMed

McMurray JJ (2016) The use of sacubitril/valsartan (LCZ696) in clinical practice. Br J Cardiol 23(suppl 1):S1-S16

U.S. Food and Drug Administration. ENTRESTO (sacubitril and valsartan). Highlights of prescribing information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207620Orig1s000lbl.pdf. Accessed 11 June 2017

Ponikowski P, Voors AA, Anker SD, Task Force Members et al (2016) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRefPubMed

Palmer BF (2004) Managing hyperkalemia caused by inhibitors of the renin–angiotensin–aldosterone system. N Engl J Med 351:585–592CrossRefPubMed

Ben Salem C, Badreddine A, Fathallah N, Slim R, Hmouda H (2014) Drug-induced hyperkalemia. Drug Saf 37:677–692CrossRefPubMed

Bistola V, Simitsis P, Farmakis D, Ikonomidis I, Bakosis G, Triposkiadis F, Hatziagelaki E, Lekakis J, Mebazaa A, Parissis J (2017) Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure. Clin Res Cardiol https://doi.org/10.1007/s00392-017-1161-7 (pMID: 28921054, [Epub ahead of print])CrossRefPubMed

Fu M, Ahrenmark U, Berglund S, Lindholm CJ, Lehto A, Broberg AM, Tasevska-Dinevska G, Wikstrom G, Ågard A, Andersson B, All investigators of the HR-HF study (2017) Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study). Clin Res Cardiol https://doi.org/10.1007/s00392-017-1146-6 (pMID: 28795299, [Epub ahead of print])PubMedPubMedCentralCrossRef

Fröhlich H, Torres L, Täger T, Schellberg D, Corletto A, Kazmi S, Goode K, Grundtvig M, Hole T, Katus HA, Cleland JGF, Atar D, Clark AL, Agewall S, Frankenstein L (2017) Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clin Res Cardiol https://doi.org/10.1007/s00392-017-1115-0 (pMID: 28434020, [Epub ahead of print])CrossRefPubMed

10.

Yancy CW, Jessup M, Bozkurt B et al (2016) ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol 68:1476–1488CrossRefPubMed

Titel: The clinical relevance of drug–drug interaction between co-trimoxazole and sacubitril/valsartan treatment in a heart failure patient: a case report and overview of mechanisms and management in clinical practice
verfasst von: Eleni S. Nakou
Maria E. Marketou
Panos E. Vardas
Fragiskos I. Parthenakis
Publikationsdatum: 01.06.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Research in Cardiology / Ausgabe 6/2018
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-018-1201-y

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The clinical relevance of drug–drug interaction between co-trimoxazole and sacubitril/valsartan treatment in a heart failure patient: a case report and overview of mechanisms and management in clinical practice

Excerpt

Neu im Fachgebiet Kardiologie

Die „Zehn Gebote“ des Endokarditis-Managements

Strenge Blutdruckeinstellung lohnt auch im Alter noch

Sind Frauen die fähigeren Ärzte?

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

Update Kardiologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

The contribution of comorbidities to mortality in hospitalized patients with heart failure

Revision: prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial

Arrhythmia-free survival and pulmonary vein reconnection patterns after second-generation cryoballoon and contact-force radiofrequency pulmonary vein isolation

Patient-specific registration of 3D CT angiography (CTA) with X-ray fluoroscopy for image fusion during transcatheter aortic valve implantation (TAVI) increases performance of the procedure

The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry

Temporal changes in outcomes of women and men undergoing percutaneous coronary intervention for chronic total occlusion: 2005–2013

Neu im Fachgebiet Kardiologie

Die „Zehn Gebote“ des Endokarditis-Managements

Strenge Blutdruckeinstellung lohnt auch im Alter noch

Sind Frauen die fähigeren Ärzte?

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

Update Kardiologie